Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

NMTR

9 Meters Biopharma (NMTR)

9 Meters Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NMTR
DateTimeSourceHeadlineSymbolCompany
22/07/202306:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NMTR9 Meters Biopharma Inc
18/07/202322:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NMTR9 Meters Biopharma Inc
19/05/202322:08Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:NMTR9 Meters Biopharma Inc
16/05/202307:28Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NMTR9 Meters Biopharma Inc
16/05/202307:27Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NMTR9 Meters Biopharma Inc
27/04/202322:18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NMTR9 Meters Biopharma Inc
07/04/202306:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NMTR9 Meters Biopharma Inc
05/04/202322:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NMTR9 Meters Biopharma Inc
01/04/202307:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NMTR9 Meters Biopharma Inc
01/04/202307:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NMTR9 Meters Biopharma Inc
30/03/202307:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NMTR9 Meters Biopharma Inc
30/03/202307:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NMTR9 Meters Biopharma Inc
28/03/202323:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NMTR9 Meters Biopharma Inc
16/03/202307:09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NMTR9 Meters Biopharma Inc
15/03/202322:40Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:NMTR9 Meters Biopharma Inc
14/03/202305:42Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NMTR9 Meters Biopharma Inc
13/03/202323:26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NMTR9 Meters Biopharma Inc
10/02/202303:59Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NMTR9 Meters Biopharma Inc
11/11/202202:10TipRanksAnalysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), 9 Meters Biopharma (NMTR) and Graphite Bio (GRPH)NASDAQ:NMTR9 Meters Biopharma Inc
10/11/202202:25TipRanksMaxim Group Remains a Hold on 9 Meters Biopharma (NMTR)NASDAQ:NMTR9 Meters Biopharma Inc
02/11/202207:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NMTR9 Meters Biopharma Inc
22/10/202207:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NMTR9 Meters Biopharma Inc
17/10/202223:43Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NMTR9 Meters Biopharma Inc
07/10/202207:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NMTR9 Meters Biopharma Inc
30/09/202206:17Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NMTR9 Meters Biopharma Inc
30/09/202206:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NMTR9 Meters Biopharma Inc
29/09/202223:35TipRanks9 Meters Biopharma (NMTR) Receives a Buy from BMO CapitalNASDAQ:NMTR9 Meters Biopharma Inc
28/09/202200:10AllPennyStocks.comBiotech Attracts Significant Premarket Buying PressureNASDAQ:NMTR9 Meters Biopharma Inc
17/08/202205:55TipRanksMaxim Group Keeps Their Hold Rating on 9 Meters Biopharma (NMTR)NASDAQ:NMTR9 Meters Biopharma Inc
16/08/202223:25TipRanks9 Meters Biopharma (NMTR) Gets a Buy from BMO CapitalNASDAQ:NMTR9 Meters Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:NMTR